scispace - formally typeset
R

Robert A. Rosenheck

Researcher at Yale University

Publications -  993
Citations -  58354

Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity.

TL;DR: E-cigarettes appear to be a viable harm reduction modality in smokers with psychiatric comorbidities, as indicated by sustained and frequent e-cigarette use by 90% of participants and may promote reduction and/or cessation of combustible cigarette use.
Journal ArticleDOI

The Diffusion of New Antipsychotic Medications and Formulary Policy

TL;DR: The evidence on the diffusion of antipsychotic medication is reviewed and the implications of formulary policies on diffusion are discussed, addressing the health care service and administrative context in which the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project is being conducted and which it is intended to inform.
Journal ArticleDOI

Sources of the Increasing Number of Vietnam Era Veterans With a Diagnosis of PTSD Using VHA Services

TL;DR: The increase in Vietnam era veterans with PTSD is associated with more frequent "conversion" to PTSD among previous VHA users and receipt of disability compensation.
Journal ArticleDOI

Medical Student Beliefs and Attitudes Toward Mental Illness Across Five Nations.

TL;DR: Differences in medical student attitudes between these five countries suggest underlying sociocultural differences in attitudes with the more stigmatized attitudes in developing countries.
Journal ArticleDOI

Impact of medical comorbidity on the quality of schizophrenia pharmacotherapy in a national VA sample.

TL;DR: In a large national sample of veterans with schizophrenia, several chronic medical conditions were associated with a decreased likelihood of being prescribed an antipsychotic medication, suggesting less intensive schizophrenia treatment.